Helo Corp. Stocks

$ 0.59Last Updated 28.04.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

$ 51.18M

Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0.59
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Helo Corp., a wellness technology company, provides wearable devices for use in the quantified-self wellness market. The company's wearable devices and related applications offer its end-users with health-related knowledge acquired through self-tracking. It offers VYYO Vista, which captures data that can be used to analyze resting and exercising heart rates, blood pressure estimation, breath rate, and energy levels, as well as provide insights into mood and sleep; and VYVO Sense, a smartband with 6 axes movement detection and an electrocardiogram (ECG) sensor. The company also provides VYVO Icon, a smartwatch that enables data to be collected to allow third parties to deduce parameters, such as body fat percentage, visceral fat levels, muscle, and bone mass; gather data to generate a third-party representation of an ECG; and provide continuous detection of possible irregular heartbeats comprising an atrial fibrillation or other arrhythmias. In addition, it offers VYVO Leggera, a smart weighing scale that can measure body weight, and has a BI sensor to capture data used to deduce bone weight, visceral fat, and body mass index; VYVO Vista+; and VYVO Watch Lite, which has data collection capabilities that enable features, including continuous atrial fibrillation detection, mood, and energy monitoring, as well as fall detection, SpO2 measurement capability, and sleep apnea detection. Further, it provides VYVO Watch Lite SE, which offers a body temperature result with an accuracy of up to ±0.1°C; and VYVO Watch Generation 2, a watch that enables medical-grade measurements with enhanced data accuracy for blood oxygen measurements, vascular aging, and ECGs. Helo Corp. sells its products through its marketing and distribution partner, VYVO HK Ltd., and its distribution network. The company was formerly known as World Technology Corp. and changed its name to Helo Corp. in October 2018. Helo Corp. was incorporated in 2010 and is headquartered in San Francisco, California.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks